Meet Idera, the Boston-area biotech that saw the biggest stock growth in 2013

While much larger biotechs like Alnylam, Celldex and Biogen Idec may have been featured in more headlines in the past year due to stock growth, it was a 20-employee company in the Central Square section of Cambridge that saw its shares rise faster than any other early-stage drug company in the state last year...